In this short video, I quickly review the difficulty in interpreting evidence guiding PDA treatment.
Management of PDA in the preterm population continues to be a hot topic with no clear resolution of the debate. Majority of the babies at or above 28 weeks would not need any specific treatment for the duct, with less than 10% of such babies needing pharmacologic treatment. In the babies under 28 weeks, a higher percentage of babies could undergo treatment-the early targeted echocardiography could be the way forward in picking which of these babies are likely to benefit. Paracetamol (15 mg/kg/dose QID) might be preferred in the first week due to better safety profile, and oral form could be more effective if baby could tolerate the oral route. Ibuprofen (traditional dose at 10-5-5 mg at 24 hour interval) is more likely to be used effectively after the first week. In more mature babies, a higher dose of Ibuprofen (20-10-10 mg at 24 hour interval) could be considered as it might be more effective.
Please review the more detailed lecture on this topic here youtu.be/w3DSh2aujE8
Please review the lecture by Dr Patrick Mcnamara here youtu.be/zzlhothGJpM
#PDA #nicu #patentductus
- Difficulty in interpreting evidence guiding PDA treatment #PDA #PDAtreatment ( Download)
- How do we diagnose PDA to guide treatment #PDA #PDAtreatment ( Download)
- Conservative approach to Patent ductus arteriosus (PDA treatment) #PDA #PDAtreatment ( Download)
- Dr Bikash BHOJNAGARWALA - PDA haemodynamic assessment - 17 02 23 ( Download)
- Dr. Alok Sharma - PDA in the preterm neonate to treat or not to treat ( Download)
- Why should we avoid overdistension, and how to approach situations where VG is not effective #nicu ( Download)
- Hemodynamic Precision in Acute Pulmonary Hypertension- Dedicated to Dr. Regan Giesinger ( Download)
- What are the causes of metabolic acidosis in babies #neonatology #acidbase #nicu ( Download)
- Treatment of congenital hypothyroidism #neonatology #hypothyroidism ( Download)
